Avotaciclib
Product Specifications
CAS Number
1983983-41-0
Target
Apoptosis, CDK
Related Pathways
Apoptosis, Cell Cycle/Checkpoint
Purity
0.9843
Bioactivity
Avotaciclib (BEY1107) is a potent, orally active cyclin-dependent kinase 1 (CDK1) inhibitor, suitable for research in locally advanced or metastatic pancreatic cancer.
Smiles
OC1=C(N=C(C=C1)C2=NC(N)=NC=C2)C3=NC(N)=NC=C3
Molecular Formula
C13H11N7O
Molecular Weight
281.27
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6123811-01 0.1 mL
VEGF-R2 (CD309, Fetal liver kinase 1 (FLK-1), KDR, Kinase insert domain receptor (a type III receptor tyrosine kinase), KRD1, Ly73, Protein tyrosine kinase receptor FLK1, Protein-tyrosine kinase receptor flk-1, Vascular endothelial growth factor receptor
Sign In for Pricing
View Details MBS6123811-02 5x 0.1 mL
VEGF-R2 (CD309, Fetal liver kinase 1 (FLK-1), KDR, Kinase insert domain receptor (a type III receptor tyrosine kinase), KRD1, Ly73, Protein tyrosine kinase receptor FLK1, Protein-tyrosine kinase receptor flk-1, Vascular endothelial growth factor receptor
Sign In for Pricing
View Details ![5-Chloro-4-isothiocyanatobenzo[c][1,2,5]thiadiazole](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
436174-01 500 mg
5-Chloro-4-isothiocyanatobenzo[c][1,2,5]thiadiazole
Sign In for Pricing
View Details 